Latest Articles

Publication Date
Short-Course Radiation Therapy Effective for Endometrial Cancer Patients - University of Utah Health Care

Short-Course Radiation Therapy Effective for Endometrial Cancer Patients University of Utah Health Care

Published: Feb. 11, 2025, 5 p.m.
American Cancer Society Awards Grant to Postdoctoral Researchers - The University of Arizona College of Medicine – Phoenix

American Cancer Society Awards Grant to Postdoctoral Researchers The University of Arizona College of Medicine – Phoenix

Published: Feb. 11, 2025, 4:12 p.m.
ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer - Pharmacy Times

ACR-368 OncoSignature Assay Receives FDA Breakthrough Device Designation for Endometrial Cancer Pharmacy Times

Published: Feb. 10, 2025, 2:34 p.m.
Contraceptive Pill Could Help Reduce Risk Of Ovarian Cancer, Study Suggests - Sepoy.net

Contraceptive Pill Could Help Reduce Risk Of Ovarian Cancer, Study Suggests Sepoy.net

Published: Feb. 10, 2025, 7:18 a.m.
FDA Grants Breakthrough Status to Endometrial Cancer Assay - www.oncnursingnews.com/

FDA Grants Breakthrough Status to Endometrial Cancer Assay www.oncnursingnews.com/

Published: Feb. 9, 2025, 3:01 p.m.
Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer - Nature.com

Inhibition of lanosterol synthase linking with MAPK/JNK signaling pathway suppresses endometrial cancer Nature.com

Published: Feb. 8, 2025, 1:17 p.m.
Uterine cancer has been impacting more Black women: Here's what to look out for - NBC Miami

Uterine cancer has been impacting more Black women: Here's what to look out for NBC Miami

Published: Feb. 6, 2025, 11:12 p.m.
GLP1R Modulates Ferroptosis and Promotes Endometrial Cancer Progression: Insights from AN3CA Cell Study - Medical Dialogues

GLP1R Modulates Ferroptosis and Promotes Endometrial Cancer Progression: Insights from AN3CA Cell Study Medical Dialogues

Published: Feb. 6, 2025, 2:45 p.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Medical Device Network

FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Medical Device Network

Published: Feb. 6, 2025, 10 a.m.
FDA grants breakthrough designation for Acrivon’s endometrial cancer assay - Yahoo! Voices

FDA grants breakthrough designation for Acrivon’s endometrial cancer assay Yahoo! Voices

Published: Feb. 6, 2025, 9:54 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!